Pineapple Financial Inc.
For the period ended Aug 31, 2025. Filed Dec 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Pineapple Financial Inc.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Pineapple Financial Inc. (the Company) as of August 31, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, changes in shareholders’ equity, and cash flows for each of the years in the two-year period ended August 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of August 31, 2025 and 2024 and the results of its operations and its cash flows for each of the years in the two-year period ended August 31, 2025, in conformity with accounting principles generally accepted in the United States of America.
Material Uncertainty Related to Going Concern
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations and has negative cash flows from operating activities which raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Chartered Professional Accountants Licensed Public Accountants
We have served as the Company’s auditor since 2020.
Mississauga, Canada
December 2, 2025
Consolidated Balance Sheets
As at August 31, 2025 and 2024
| As at: · August 31, 2025 · August 31, 2024 | |||
|---|---|---|---|
| $ · $ | |||
| Assets | |||
| Current assets | |||
| Cash | 2,117,371 | 580,356 | |
| Trade and other receivables | Note 14 | 92,223 | 155,224 |
| Prepaid expenses and deposits | 110,001 | 157,911 | |
| Total current assets | 2,319,595 | 893,491 | |
| Investment | Note 4 | 9,733 | 10,042 |
| Right-of-use asset - net | Note 10 | 530,163 | 828,674 |
| Property and equipment - net | Note 5 | 61,957 | 152,610 |
| Intangible assets - net | Note 6 | 2,495,773 | 2,211,775 |
| Total Assets | 5,417,221 | 4,096,592 | |
| Liabilities and Shareholders’ Equity | |||
| Current liabilities | |||
| Accounts payable and accrued liabilities | 2,125,160 | 1,125,477 | |
| Deferred revenue | Note 13 | 108,552 | 111,921 |
| Loan from directors | Note 17 | 629,120 | - |
| Current portion of lease liability | Note 10 | 138,859 | 161,508 |
| Total current liabilities | 3,001,691 | 1,398,906 | |
| Deferred government incentive | Note 13 | 314,998 | 491,251 |
| Lease liability | Note 10 | 561,100 | 815,599 |
| Warrant liability | Note 8 | 632,753 | 41,520 |
| Total liabilities | 4,510,542 | 2,747,276 | |
| Shareholders’ Equity | |||
| Common shares (*), no par value; unlimited authorized; 1,340,941 issued and outstanding shares as of August 31, 2025 and 421,342 as at August 31, 2024. | Note 7 | 11,621,468 | 8,559,856 |
| Common shares to be issued | 88,136 | - | |
| Additional paid-in capital | Note 8,9 | 3,102,814 | 2,955,944 |
| Accumulated other comprehensive loss | (509,300) | (408,510) | |
| Accumulated deficit | (13,396,439) | (9,757,974) | |
| Total stockholders’ equity | 906,679 | 1,349,316 | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 5,417,221 | 4,096,592 | |
Description of business (note 1)
Going concern (note 1)
Contingencies and commitments (note 15)
Subsequent events (note 21)
| (*) | On July 16, 2025, the Company effected a 1-for-20 reverse stock split of its issued and outstanding common shares. All share and per-share information in the consolidated financial statements and accompanying notes has been retroactively adjusted to reflect the reverse split. The reverse stock split did not affect the Company’s total shareholders’ equity. |
|---|
Approved on behalf of Board of Directors
| “Shuba Dasgupta” | “Drew Green” |
|---|
Consolidated Statements of Operations and Comprehensive Loss
| For the year ended · August 31, 2025 · August 31, 2024 | |||
|---|---|---|---|
| $ · $ | |||
| Revenue | Note 16 | 2,986,823 | 2,688,987 |
| Expenses | |||
| Selling, general and administrative | Note 11 | 2,253,944 | 2,382,225 |
| Advertising and marketing | 669,482 | 860,047 | |
| Salaries, wages and benefits | 1,645,024 | 2,436,783 | |
| Interest expense and bank charges | 336,115 | 93,472 | |
| Depreciation and amortization | Note 5,6,10 | 862,104 | 838,843 |
| Share-based compensation | Note 9 | 235,006 | - |
| Government incentive | Note 13 | (70,555) | (97,646) |
| Loss on derecognition of right of use of asset | 3,596 | - | |
| Total expenses | 5,934,716 | 6,513,724 | |
| Loss from operations | (2,947,893) | (3,824,737) | |
| (Loss) on extinguishment of liability | Note 18 | - | (156,339) |
| Foreign exchange gain (loss) | 10,133 | (38,836) | |
| Gain on change in fair value of warrant liability | Note 8 | (608,537) | 63,769 |
| Gain on change in fair value of conversion feature liability | Note 18 | - | 76,543 |
| Financing cost – warrant issuance | Note 8 | (164,280) | - |
| Accretion expense | Note 18 | - | (223,059) |
| Other income | Note 20 | 72,112 | - |
| Net loss | (3,638,465) | (4,102,659) | |
| Foreign currency translation adjustment | 100,790 | 9,217 | |
| Net loss and comprehensive loss | (3,537,675) | (4,093,442) | |
| Net loss per share - basic and diluted | (5.31) | (11.46) | |
| Weighted average number of common shares (*) outstanding - basic and diluted (numbers) | 665,820 | 357,297 | |
| (*) | On July 16, 2025, the Company effected a 20-for-1 reverse stock split of its issued and outstanding common shares. All share and per-share information presented in the consolidated financial statements, including weighted-average shares outstanding, EPS, and disclosures related to stock options, RSUs, and warrants, have been retroactively adjusted to reflect the reverse stock split for all periods presented. |
|---|
Consolidated Statements of Shareholders’ Equity
| Additional · Accumulated | ||||||
|---|---|---|---|---|---|---|
| Common | Common | Paid in | other | Accumulated | Total | |
| Shares | shares to | Capital | comprehensive | (deficit) | shareholders’ | |
| (note 7) | be issued | (note 8 and 9) | loss | earnings | equity | |
| $ | $ | $ | $ | $ | $ | |
| Balance, August 31, 2023 | 4,903,031 | - | 2,955,944 | (417,727) | (5,655,315) | 1,785,933 |
| Shares issued on Initial Public offering on November 3, 2023 | 2,751,937 | - | - | - | - | 2,751,937 |
| Shares issued against convertible note | 465,680 | - | - | - | - | 465,680 |
| Shares issued against equity purchase agreement | 487,491 | - | - | - | - | 487,491 |
| Warrants issued related to Initial Public Offering | (48,283) | - | - | - | - | (48,283) |
| Foreign exchange translation | - | - | - | 9,217 | - | 9,217 |
| Net loss | - | - | - | - | (4,102,659) | (4,102,659) |
| Balance, August 31, 2024 | 8,559,856 | - | 2,955,944 | (408,510) | (9,757,974) | 1,349,316 |
| Shares issued on follow up public offering | 1,847,477 | - | - | - | - | 1,847,477 |
| Shares issued against warrants exercise | 1,701,398 | - | - | - | - | 1,701,398 |
| Shares against Directors and Employees Stock options and restricted share units | 88,136 | 146,870 | - | - | 235,006 | |
| Shares issue cost | (487,263) | - | - | (487,263) | ||
| Foreign exchange translation | - | - | (100,790) | - | (100,790) | |
| Net loss | - | - | - | (3,638,465) | (3,638,465) | |
| Balance, August 31, 2025 | 11,621,468 | 88,136 | 3,102,814 | (509,300) | (13,396,439) | 906,679 |
Consolidated Statements of Cash Flow
| For the year ended: · August 31, 2025 · August 31, 2024 | |||
|---|---|---|---|
| $ · $ | |||
| Cash provided by (used for) the following activities | |||
| Operating activities | |||
| Net loss for the year | (3,638,465) | (4,102,659) | |
| Adjustments for the following non-cash items: | |||
| Depreciation of property and equipment | Note 5 | 82,113 | 87,803 |
| Amortization of intangible assets | Note 6 | 592,942 | 616,532 |
| Depreciation on right of use asset | Note 10 | 187,048 | 134,508 |
| Bad debts written off | 48,524 | 7,545 | |
| Interest expense on lease liability | Note 10 | 51,431 | 62,604 |
| Share-based compensation | Note 9 | 235,006 | - |
| Loss on derecognition of right of use of asset | 3,596 | - | |
| Change in fair value of warrant liability | 608,537 | 63,769 | |
| Accretion expense | - | 223,059 | |
| Loss on extinguishment of liability | - | 156,339 | |
| Gain (loss) on change in fair value of the conversion feature liability | - | (76,543) | |
| Derecognition of right of use of assets | - | ||
| Unrealized foreign exchange gain (loss) | - | 38,836 | |
| Net changes in non-cash working capital balances: | |||
| Trade and other receivables | 14,477 | 596,219 | |
| Prepaid expenses and deposits | 47,910 | 60,239 | |
| Accounts payable and accrued liabilities | 999,683 | 519,943 | |
| Deferred government incentive | (176,253) | (208,376) | |
| Deferred revenue | (3,369) | 111,921 | |
| Net cash used in operating activities | (946,820) | (1,708,261) | |
| Financing activities | |||
| Share capital issuance | Note 7 | 1,847,477 | 2,751,937 |
| Loan from directors | Note 17 | 629,120 | - |
| Exercise of share warrants | Note 7 | 1,008,798 | - |
| Warrant liability allocation on share capital issuance | Note 8 | 659,190 | - |
| Share issue cost | (487,313) | - | |
| Proceed from conversion note | Note 18 | - | 300,000 |
| Proceed from equity purchase agreement | - | 487,491 | |
| Proceed from scientific research and development loan | - | 87,369 | |
| Repayment of scientific research and development loan | Note 13 | - | (517,467) |
| Repayment of lease obligations | Note 10 | (206,185) | (196,703) |
| Net cash provided by financing activity | 3,451,087 | 2,912,627 | |
| Investing activities | |||
| Additions to intangible assets | Note 6 | (944,187) | (1,112,399) |
| Additions to property and equipment | Note 5 | - | (4,991) |
| Net cash used in investing activity | (944,187) | (1,117,390) | |
| Net change in cash | 1,560,080 | 86,976 | |
| Effect of changes in foreign exchange rates | (23,065) | (226,985) | |
| Cash, beginning of year | 580,356 | 720,365 | |
| Cash, end of year | 2,117,371 | 580,356 | |
| Supplementary cash flow information: | |||
| Interest paid | 218,512 | 35,281 | |
| Income taxes paid | - | - | |
1. Description of business
Pineapple Financial Incorporation, (“the Company”) was incorporated in 2006, under the Ontario Business Corporations Act. Later the company was registered under Canadian Business Corp. The Company’s head office is located at 200-111 Gordon Baker Road, Toronto, Ontario, M2H 3R1 Canada and its securities are publicly listed on the New York Stock Exchange American (NYSEAmerican) under ticker “PAPL”.
Impact from the global inflationary pressures leading to higher interest rates
During fiscal 2024, global inflationary pressures resulted in central banks, including the Bank of Canada, increasing benchmark interest rates to mitigate inflation. The resulting higher borrowing costs led to a slowdown in real-estate activity, reduced pricing pressures, and lower transaction volumes across the housing market.
In fiscal 2025, the Bank of Canada began to gradually reduce interest rates as inflationary trends moderated and economic conditions softened. While these decreases are expected to improve housing affordability and support market recovery over time, the full impact on the real-estate sector and related businesses remains uncertain as of August 31, 2025.
Going Concern
The Company continues to incur significant operating losses and negative operating cash flows, a trend expected to persist in the near term. For the year ended August 31, 2025, the Company incurred a net loss of $3,638,465 (2024 - $4,102,659) and reported negative cash flows from operating activities of $946,820 (2024 - $1,708,261). As at August 31, 2025, the Company had an accumulated deficit of$13,396,439 (2024 – $9,757,974) and a working capital deficit of $682,096 (2024 - $505,415), indicating that current assets are not sufficient to discharge existing liabilities as they become due. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
Management’s ability to sustain operations depends on realizing assets and managing obligations as they come due, as well as securing additional financial resources. Subsequent to year-end, the Company entered into the Injective Digital Asset Treasury Initiative, pursuant to which the Company expects to receive approximately $2.1 million upon the timely filing of its Form S-1. In addition, the Company completed an investment of $11.4 million in Injective tokens, which management anticipates may generate future economic benefits through potential fair-value appreciation.
Management’s plans to address these conditions include:
| 1. | securing the proceeds expected under the Injective initiative, |
| 2. | pursuing additional capital and financing arrangements, and |
| 3. | implementing further cost-containment and working capital measures. |
These plans are discussed further in Note 21, Subsequent Events. There is no assurance that these initiatives will be achieved as planned. Accordingly, substantial doubt remains regarding the Company’s ability to continue as a going concern.
2. Significant accounting policies
Statement of compliance
These consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“US GAAP”).
The consolidated financial statements were authorized for issue by the Board of Directors on November ___, 2025.
Basis of preparation, functional and presentation currency
The consolidated financial statements have been prepared in accordance with US GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business on the historical cost basis except for certain financial instruments that are measured at fair value, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets. All financial information is in US Dollars (“USD”) as the Company’s presentation currency and transactions are conducted in the functional currency of Canadian dollars (“CAD”).
Adjustment for Reverse Stock Split
In July 2023, the Board of Directors approved a 1-for-3.9 reverse stock split (the “2023 Reverse Split”), which became effective on July 14, 2023.
On July 16, 2025, the Company effected a 1-for-20 reverse stock split of its issued and outstanding common shares. The reverse split did not affect the total shareholders’ equity of the Company or the par value of the common shares. All share, option, warrant and restricted share unit (“RSU”) amounts, as well as all per-share information presented in these consolidated financial statements, have been retroactively adjusted to reflect the reverse stock split for all periods presented.
Operating segments
The Company determines its reporting units in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 280, Segment Reporting. The Company evaluates a reporting unit by first identifying its operating segments under ASC 280. The Company operates asone operating segment which is reported in a manner consistent with the internal reporting provided to the chief operating decision-makers. The chief operating decision-makers are responsible for the allocation of resources and assessing the performance of the operating segment and have been identified as the CEO and CFO of the Company.
| 2. | Significant accounting policies (continued from previous page) |
Basis of consolidation
The consolidated financial statements include the accounts of the Company, and its wholly owned subsidiary, Pineapple Insurance Inc and Pineapple National Inc. All transactions with the subsidiaries and any intercompany balances, gains or losses have been eliminated upon consolidation. The subsidiaries have a USD presentation currency, and the functional currency is in CAD, and accounting policies have been applied consistently to the subsidiaries.
ASC 842 Leases
At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, less any lease incentives received.
The right-of-use assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate.
The Company recognized a lease liability and right-of-use asset for most leases and applied ASC 842. The lease liability was measured at the present value of the remaining lease payments, discounted using the Company’s estimated incremental borrowing rate at the date of initial application. Right-of-use assets were measured at an amount equal to the lease liability, adjusted by the amount of any prepaid or accrued lease payments relating to that lease recognized in the consolidated statement of financial position immediately before the date of initial application.
Financial instruments
The following table shows the classification categories under US GAAP ASC 825 for each class of the Company’s financial assets and financial liabilities.
| Asset / liability: | Classification: |
|---|---|
| Cash | FVTPL |
| Trade and other receivables | Amortized cost |
| Investments | FVTPL |
| Accounts payable and accrued liabilities | Amortized cost |
| Loan | Amortized cost |
| Warrant liability | FVTPL |
Financial assets
Recognition and initial measurement
The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.
| 2. | Significant accounting policies (continued from previous page) |
Classification and subsequent measurement
On initial recognition, financial assets are classified and subsequently measured at amortized cost, fair value through other comprehensive income (“FVOCI”) or fair value through profit or loss (“FVTPL”). The Company determines the classification of its financial assets, together with any embedded derivatives, based on the business model for managing the financial assets and their contractual cash flow characteristics.
Financial assets are classified as follows:
| ● | Amortized cost - Assets that are held for collection of contractual cash flows where those cash flows are solely payments of principal and interest are measured at amortized cost. Interest revenue is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of trade and other receivables. |
| ● | Fair value through other comprehensive income - Assets that are held for collection of contractual cash flows and for selling the financial assets, and for which the contractual cash flows are solely payments of principal and interest, are measured at fair value through other comprehensive income. Interest income calculated using the effective interest method and gains or losses arising from impairment and foreign exchange are recognized in profit or loss. All other changes in the carrying amount of the financial assets are recognized in other comprehensive income. Upon derecognition, the cumulative gain or loss previously recognized in other comprehensive income is reclassified to profit or loss. The Company does not hold any financial assets measured at fair value through other comprehensive income. |
| ● | Mandatorily at fair value through profit or loss - Assets that do not meet the criteria to be measured at amortized cost, or fair value through other comprehensive income, are measured at fair value through profit or loss. All interest income and changes in the financial assets’ carrying amount are recognized in profit or loss. Financial assets mandatorily measured at fair value through profit or loss are comprised of cash and investments. |
| ● | Designated at fair value through profit or loss – On initial recognition, the Company may irrevocably designate a financial asset to be measured at fair value through profit or loss in order to eliminate or significantly reduce an accounting mismatch that would otherwise arise from measuring assets or liabilities, or recognizing the gains and losses on them, on different bases. All interest income and changes in the financial assets’ carrying amount are recognized in profit or loss. The Company does not hold any financial assets designated to be measured at fair value through profit or loss. |
Contractual cash flow assessment
The cash flows of financial assets are assessed as to whether they are solely payments of principal and interest on the basis of their contractual terms. For this purpose, ‘principal’ is defined as the fair value of the financial asset on initial recognition. ‘Interest’ is defined as consideration for the time value of money, the credit risk associated with the principal amount outstanding, and other basic lending risks and costs. In performing this assessment, the Company considers factors that would alter the timing and amount of cash flows such as prepayment and extension features, terms that might limit the Company’s claim to cash flows, and any features that modify consideration for the time value of money.
| 2. | Significant accounting policies (continued from previous page) |
Financial instruments (continued from previous page)
Impairment
The Company recognizes a loss allowance for the expected credit losses associated with its financial assets, other than financial assets measured at fair value through profit or loss. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions, and forecasts of future economic conditions.
The Company applies the simplified approach for trade receivables. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets’ contractual lifetime.
The Company assesses whether a financial asset is credit-impaired at the reporting date. Regular indicators that a financial instrument is credit-impaired include significant financial difficulties as evidenced through borrowing patterns or observed balances in other accounts and breaches of borrowing contracts such as default events or breaches of borrowing covenants. For financial assets assessed as credit- impaired at the reporting date, the Company continues to recognize a loss allowance equal to lifetime expected credit losses.
For financial assets measured at amortized cost, loss allowances for expected credit losses are presented in the statements of financial position as a deduction from the gross carrying amount of the financial asset.
Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.
Derecognition of financial assets
The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.
Financial liabilities
Recognition and initial measurement
The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, except for financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.
Where an instrument contains both a liability and equity component, these components are recognized separately based on the substance of the instrument, with the liability component measured initially at fair value and the equity component assigned the residual amount.
Classification and subsequent measurement
Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains and losses relating to a financial liability are recognized in profit or loss.
Derecognition of financial liabilities
The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.
| 2. | Significant accounting policies (continued from previous page) |
Financial instruments (continued from previous page)
Fair value
Assets and liabilities carried at fair value must be classified using a three-level hierarchy that reflects the significance and transparency of the inputs used in making the fair value measurements.
| Level 1 | inputs are unadjusted quoted prices of identical instruments in active markets; |
| Level 2 | inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and |
| Level 3 | inputs that are not based on observable market data (unobservable data). |
Determination of fair value and the resulting hierarchy requires the use of observable market data whenever available. The classification of a financial instrument in the hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. Cash is recorded at fair value using level 1 inputs and investments are recorded at fair value using level 3 inputs and warrant liability is measured using level 2 inputs. During the year, there were no transfers between the levels of fair value.
Income taxes
Income tax expense includes U.S. and international income taxes, and interest and penalties on uncertain tax positions. Certain income and expenses are not reported in tax returns and financial statements in the same year. The tax effect of such temporary differences is reported as deferred income taxes. Deferred tax assets are reported net of a valuation allowance when it is more likely than not that a tax benefit will not be realized. All deferred income taxes are classified as long-term in our consolidated balance sheets.
In December 2023, the FASB issued a new standard to improve income tax disclosures. The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The standard will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are currently evaluating the impact of this standard on our income tax disclosures.
Share Capital
Common shares are classified as equity. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from shareholders’ equity.
| 2. | Significant accounting policies (continued from previous page) |
Earnings per share
The Company computes basic and diluted earnings per share (“EPS”) in accordance with ASC 260, Earnings per Share.
Basic EPS is calculated by dividing net income (loss) attributable to common shareholders by the weighted-average number of common shares outstanding during the reporting period.
Diluted EPS is calculated by adjusting both the numerator and the denominator of the basic EPS calculation for the effects of all potential common shares that are dilutive. Potential common shares include stock options, warrants, and restricted share units (RSUs). These instruments are considered dilutive only when their assumed conversion or exercise would decrease earnings per share or increase loss per share from continuing operations.
For the years presented, potential common shares were anti-dilutive due to net losses and therefore were excluded from the diluted EPS calculation. Accordingly, basic and diluted loss per share are the same for all periods.
All share and per-share information has been retroactively adjusted to reflect the Company’s 20-for-1 reverse stock split, which was approved by the Board of Directors and implemented in July 16 th, 2025. The reverse stock split did not affect the total shareholders’ equity or par value of the common shares.
Share-based payment arrangements
Equity-settled share-based payments to employees and others providing similar services are measured at the fair value of the equity instruments at the grant date. Details regarding the determination of the fair value of equity-settled share-based transactions are set out in Note 9.
The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of equity instruments that will eventually vest, with a corresponding increase in equity. At the end of each reporting period, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in profit or loss such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to the additional paid-in capital.
Equity-settled share-based payment transactions with parties other than employees are measured at the fair value of the goods or services received, except where that fair value cannot be estimated reliably, in which case they are measured at the fair value of the equity instruments granted, measured at the date the entity obtains the goods or the counterparty renders the service.
Property and equipment
Property and equipment are recorded at cost, net of accumulated depreciation and accumulated impairment losses, if any. Cost includes all expenditures incurred to bring the assets to the location and condition necessary for them to be operated in the manner intended by management.
Depreciation is calculated using the following terms and methods:
| Equipment | 5 years | Straight Line |
| Furniture | 5 years | Straight Line |
| IT Equipment | 3 years | Straight Line |
| Leasehold Improvement | 5 years | Straight Line |
| Laptops | 3 years | Straight Line |
An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in profit or loss in the year the asset is derecognized.
| 2. | Significant accounting policies (continued from previous page) |
Intangible Assets
Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses.
Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:
| ● | The costs attributable to the asset can be measured reliably. |
| ● | It is probable that the intangible asset will generate future economic benefits. |
| ● | The Company can demonstrate the control and ability to use the intangible asset. |
The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statement of operations and comprehensive loss in the period in which the expense is incurred.
Intangible assets with finite lives are amortized over the estimated useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the consolidated statements of operations and comprehensive loss and in the expense category that is consistent with the function of the intangible assets.
Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis.
An intangible asset is derecognized upon disposal (i.e., at the date the recipient obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statement of operations and comprehensive loss.
Cost includes all expenditures incurred to bring the assets to the location and condition necessary for them to be operated in the manner intended by management.
Amortization is calculated using the following terms and methods:
| Software | 7 years | Straight Line |
Revenue recognition
The Company generates its revenue by charging commissions on mortgages that are applied for through the automation and digitalization process that the Company has in place.
| 2. | Significant accounting policies (continued from previous page) |
Revenue recognition (continued)
The Company has adopted ASC 606 (Revenue from Contracts with Customers). The standard provides a single comprehensive model for revenue recognition. The core principle of the standard is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard introduced a new contract-based revenue recognition model with a measurement approach that is based on an allocation of the transaction price. It establishes a five-step model to account for revenue arising from contracts with customers. Under ASC 606, revenue is recognized at an amount that reflects the consideration to which an entity expects to be entitled in exchange for transferring good or services to a customer. The standard requires entities to exercise Judgment, taking into consideration all of the relevant facts and circumstances when applying each step of the model to contracts with customers. The standard also specifies the accounting for incremental costs of obtaining a contract and the costs directly related to fulfilling a contract.
Revenue is recognized at an amount that reflects the consideration to which the Company is expected to be entitled in exchange for transferring goods or services to a customer.
Rendering of services – The Company hosts an online website, that brokers and agents can utilize to close out deals.
The Company’s subsidiary, Pineapple Insurance Inc., generates its revenue by charging commission on for insurance policies and services. Pineapple Insurance is associated with a major insurance company from which it earns commissions for the provision of these services, primarily mortgage insurance. Mortgage insurance is a requirement of each mortgage. Pineapple Insurance has also adopted ASC 606. Typically, Pineapple Insurance is the agent supplying insurance services to the consumer and paid a commission from the premiums collected by the insurance company whose products and services it provides to the end consumer.
The Company has five revenue streams:
| a) | Sales Revenue is commission collected from financial institutions with whom it has contracts in place. The company earns revenue based on a percentage of mortgage amount funded between individual referred by the company and financial institutions funding the mortgage. Pineapple Financial Inc. acts as agent in these deals as we provide the platform for other parties to provide services to the end-user. For each contract with a customer, the company identifies the contract with a customer; identifies the performance obligations in the contract; determines the transaction price to the separate performance obligations on the basis of the relative stand-alone selling price of each distinct good or service to be delivered; and recognizes revenue when or as each performance obligation is satisfied in a manner that depicts the transfer to the customer of the goods or services promised. The company recognizes revenue when: a contract exists with a lender party and an agent broker, the contract identifies the use of the platform service to close a mortgage deal, the mortgage deal has been closed with the lending financial institution, and commissions paid by the lending financial institution based on various criteria of the mortgage deal including but not limited to interest rates available at that time, term, seasonality, collateral, income, purpose, etc. Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable for services provided in the normal course of business. Revenue is recognized at the end of the deal upon completion of all the actions listed above. A typical transaction attracts a commission fee payable to Pineapple Financial Inc. |
| b) | Subscription Revenue is a flat fee that is charged to the brokers and agents for use of the platform. Revenue is recognized over the service period. |
| c) | Underwriting Revenue is a flat fee charged for risk pre-assessment of the deal before it is submitted to the Lender Partner for funding. The flat fee is based on the amount of funded volume being financed in the deal. Revenue is recognized at the end of the deal upon completion of the actions listed in a). |
| d) | Sponsorship revenue is received from lenders to promote their brands at company events. Company received the revenue in advance and any unused sponsorship revenue is treated as deferred revenue. |
| e) | The Company earns insurance commission revenue through its Pineapple Insurance division, which facilitates the placement of insurance policies with third-party carriers. In evaluating whether the Company acts as a principal or an agent in these arrangements, management considered who controls the insurance product and which party is primarily responsible for fulfilling the policy obligation. The Company concluded that it acts as an agent in these transactions. Insurance carriers determine the premium, underwriting criteria, coverage terms, and assume all associated insurance and claims risk. Pineapple’s role is limited to connecting customers with the insurance provider, collecting required information, and facilitating the policy application process. Because the Company does not control the insurance product before it is transferred to the customer, revenue is recognized on a net basis, representing only the commission retained by the Company after remitting any applicable referral or agent-related amounts. |
| 2. | Significant accounting policies (continued from previous page) |
Impairment of non-financial assets
Property and equipment, and intangible assets (other than goodwill) are tested for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. When an indication of impairment is identified, the carrying value of the asset or group of assets is measured against the recoverable amount. The Company evaluates impairments losses, other than goodwill impairment, for potential reversals when events or circumstances warrant such consideration.
Principal versus Agent considerations
Judgment is required in determining whether the Company is a principal or agent in transactions with the lending financial institutions (“Lender Partner”). The Company evaluates the presentation of revenue on a gross basis, or a net basis based on whether the Company controls the service provided to the end user and are the principal (i.e., “Gross”) or the Company arranges the brokers to provide the service to the end user and are an agent ( i.e., “Net”). This determination impacts the presentation of the commission payable to the brokers.
For the transactions with the Lender partner our role is to provide instructions to the brokers on the information required from homeowners to complete a successful mortgage application that would be presented to the Lender partner to review and accept and pay a commission to Pineapple for facilitating a successful mortgage application. The Company concluded that the control of the mortgage application is with brokers as the ultimate information that is to be obtained from the homeowners to provide to the lender partner is controlled by the broker and the Company only facilitates the information transfer from the broker to the Lender partner to obtain mortgage for the homeowner as such the Company is an agent.
For insurance-related commissions, the Company also assessed whether it acts as a principal or an agent in transactions with third-party insurance providers. The insurance providers control the key aspects of the insurance product, including the underwriting criteria, pricing of premiums, policy terms, and assumption of all associated risk. The Company’s role is limited to facilitating the referral of clients to the licensed insurance providers and assisting brokers in gathering and transmitting the information required to complete the insurance application process. Because the Company does not control the insurance service before it is transferred to the customer and does not bear underwriting or pricing risk, the Company concluded that it is acting as an agent in these transactions. Accordingly, insurance commissions are presented on a net basis.
Provisions
A provision is recognized when the Company has a present legal or constructive obligation as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation, and the amount of the obligation can be reliably estimated. The amount of a provision is the best estimate of the consideration at the end of the reporting period. Provisions measured using estimated cash flows required to settle the obligation are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.
A provision for onerous contracts is recognized when the expected benefits to be derived by the Company from a contract are lower than the unavoidable cost of meeting its obligations under the contract. The Company had no material provisions as at August 31, 2025 and 2024.
Deferred government grant
Government grants are recognized when there is reasonable assurance that the grants will be received and the company will comply with the conditions. The grants is deferred and recognized as a liability and is recognized in the statement of operations and compressive loss over the useful life of the intangible asset.
Recently issued and adopted accounting standards*:*
As an “emerging growth company,” as defined under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), the Company is permitted to delay adoption of new or revised accounting pronouncements applicable to public business entities until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period provided under the JOBS Act. Accordingly, the adoption dates discussed below reflect this election.
| Recently Adopted | |
|---|---|
| 1. | In December 2023, the FASB issued ASU 2023-09 - Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This standard modifies the rules on income tax disclosures to require entities to disclose specific categories in the rate reconciliation, the income or loss from continuing operations before income tax expense or benefit, and income tax expense or benefit from continuing operations. ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state, and local jurisdictions. The ASU is effective for years beginning after December 15, 2024, but early adoption is permitted. This ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of this standard on its financial statements and disclosures. |
| 2. | In March 2024, the FASB issued ASU 2024-01 - Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards. This standard clarifies whether profits interest and similar awards fall within the scope of stock-based compensation guidance as defined in ASC Topic 718, introducing examples to demonstrate this. The ASU includes scenarios where profits interest awards are classified as equity instruments or liability awards and situations where they fall outside ASC Topic 718, being accounted for under ASC Topic 710. The ASU is effective for years beginning after December 15, 2024, but early adoption is permitted. This ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of this standard on its financial statements and disclosures. |
| 3. | In January 2025, the FASB issued ASU 2025-01 - Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. This standard amends the guidance issued in 2024 to confirm that all public business entities must present the required expense-disaggregation disclosures in annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. The ASU is effective for years beginning after those dates, but early adoption is permitted. This ASU should be applied on a prospective basis, although retrospective application is permitted. Because the amendment only affects disclosure timing, the Company does not expect this standard to have a material impact on its financial statements and disclosures. |
| 4. | In June 2025, the FASB issued ASU 2025-03 - Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in a Variable-Interest Entity. This standard clarifies that when a business combination is effected primarily by exchanging equity interests and the legal acquiree is a variable-interest entity (“VIE”) that meets the definition of a business, entities must identify the accounting acquirer using the factors in ASC 805-10-55-12 through 55-15, rather than relying solely on the VIE consolidation model. The ASU is effective for years beginning after December 15, 2026, but early adoption is permitted. This ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of this standard on its financial statements and disclosures. |
3. Significant accounting judgments, estimates and assumptions
The preparation of consolidated financial statements requires the directors and management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.
The following are the critical estimates and judgments applied by management that most significantly affect the Company’s consolidated financial statements. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in future periods.
Investments (level 3)
Where the fair values of financial assets and financial liabilities recorded on the consolidated statements of financial position, cannot be derived from active markets, they are determined using a variety of valuation techniques. The inputs to these models are derived from observable market data where possible; where observable market data is not available, Management’s judgment is required to establish fair values.
Expected credit losses (ECL)
The Company applies the expected credit loss model to accounts receivable in accordance with ASC 326. Determining the allowance for expected credit losses requires management judgment in assessing historical collection trends, customer creditworthiness, current economic conditions and forward-looking information. Because these factors may change over time, the allowance involves a degree of estimation uncertainty, and actual credit losses may differ from management’s estimates.
Share based compensation
The Company accounts for share-based compensation in accordance with ASC 718 — Compensation — Stock Compensation. The Company’s share-based awards include stock options and restricted stock units (“RSUs”) granted to directors, officers, and employees.
Stock options
Certain stock options granted in prior fiscal years contain a service-based vesting period of up to 36 months. The fair value of these options is determined on the grant date using the Black-Scholes option-pricing model, which incorporates assumptions regarding share-price volatility, risk-free interest rates, expected dividend yields, and expected option life. Compensation expense for these awards is recognized on a straight-line basis over the vesting period.
During the current fiscal year, the Company granted stock options to directors and employees for services previously rendered. These awards were fully vested at the grant date and therefore did not contain any service or performance vesting conditions. The fair value of these immediately vested options was determined using the Black-Scholes model as of the grant date, and the entire fair value was recognized immediately as share-based compensation expense in the consolidated statements of income and comprehensive income.
Restricted stock units (RSUs)
RSUs granted during the current fiscal year were also issued in consideration of past services and were fully vested at the date of grant. The fair value of RSUs is based on the market price of the Company’s common shares on the grant date, and the full fair value was recognized as compensation expense immediately upon issuance.
The Company records share-based compensation expense separately. For awards that are fully vested upon grant, no estimates of forfeitures, expected terms, or future service periods are required. For any future awards subject to vesting, compensation expense will be recognized on a straight-line basis over the requisite service period.
Warrant liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations and comprehensive loss.
The warrants are not precluded from equity classification and are accounted for as such on the date of issuance and will be on each consolidated balance sheet date thereafter. As the warrants are equity classified, they are initially measured at fair value (or allocated value).
Derivative financial instrument
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,Derivatives and Hedging (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. For derivative instruments that are classified as equity, the derivative instruments are initially measured at fair value (or allocated value), and subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.
Going concern
Preparation of the consolidated financial statement on a going concern basis, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Should the Company be unable to continue as a going concern, it may be unable to realize the carrying value of its assets, including its intangible assets and to meet its liabilities as they become due.
| 3. | Significant accounting judgments, estimates and assumptions (continued) |
Useful life of Assets
Property, plant and equipment
Property, plant and equipment are recorded at cost, less accumulated depreciation and impairment losses, if any. Depreciation is provided using the straight-line method over the estimated useful lives of the assets. Expenditures for maintenance and repairs are expensed as incurred, while major renewals and improvements are capitalized. Gains and losses on disposals are recognized in the consolidated statements of operations and comprehensive loss when assets are retired or otherwise disposed of.
Management periodically reviews the estimated useful lives of property and equipment to ensure they reflect the assets’ expected economic benefit. No changes in useful life estimates were made during the year ended August 31, 2025.
Intangible assets
Intangible assets consist primarily of internally developed or acquired software and technology platforms used in the Company’s operations. These assets are amortized on a straight-line basis over their estimated useful lives, which are currently seven years.
In June 2024, the Company reassessed the expected economic benefit of certain software assets and increased their estimated useful life from five years toseven years. That change in estimate was accounted for prospectively in accordance with ASC 250 – Accounting Changes and Error Corrections. No further revisions to useful life estimates were made during the fiscal year ended August 31, 2025.
The Company evaluates intangible assets for indicators of impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable, in accordance with ASC 350 and ASC 360. No indicators of impairment were identified during the year.
Impairment of Non-Current Assets
The Company reviews its long-lived assets, including property and equipment and capitalized software development costs, for indicators of impairment in accordance with ASC 360 -Property, Plant, and Equipment and ASC 350 -Intangibles-Goodwill and Other. Significant judgment is required in assessing whether triggering events have occurred and in estimating the recoverable amount of these assets.
When indicators of impairment are identified, the Company estimates the asset’s future undiscounted cash flows to determine whether the carrying amount is recoverable. If not recoverable, the impairment loss is measured as the excess of the carrying amount over fair value, which is based on discounted cash flows or other valuation techniques. These estimates require management to make assumptions regarding expected future economic conditions, product performance, technology life cycles, and the useful lives of assets.
No impairment charges were recognized during the years ended August 31, 2025 and 2024; however, changes in underlying assumptions may result in material impairment in future periods.
4. Investment
The fair value of the Company’s 5% investment in a private company is determined using Level 3 inputs under ASC 820. Management assesses fair value annually using a market-approach valuation technique, considering factors such as the investee’s financial performance, recent arm’s-length transactions, and comparable private-company multiples. For the years ended August 31, 2025 and 2024, no observable changes in these inputs or in the investee’s financial condition were identified; accordingly, management concluded that the fair value remained unchanged. Any translation differences are recorded through earnings.
5. Property and equipment
The Company’s property and equipment consist of equipment, furniture, IT equipment, leasehold improvements and laptops.
| Property and equipment | |
|---|---|
| Cost | |
| Balance, August 31, 2023 | $349,283 |
| Additions | 4,991 |
| Translation adjustment | 569 |
| Balance, August 31, 2024 | $355,576 |
| Disposal | (6,357) |
| Translation adjustment | (17,342) |
| Balance, August 31, 2025 | $338,234 |
| Accumulated depreciation | |
| Balance, August 31, 2023 | $107,192 |
| Depreciation | 87,803 |
| Translation adjustment | 7,971 |
| Balance, August 31, 2024 | $202,966 |
| Depreciation | 82,113 |
| Disposal | (2,761) |
| Translation adjustment | (8,802) |
| Balance, August 31, 2025 | $276,277 |
| Net carrying value | |
| August 31, 2025 | $61,957 |
| August 31, 2024 | $152,610 |
**6. Intangible assets **
During the current year, the Company capitalized development costs related to internally generated software classified as intangible assets.
| Intangible assets | |
|---|---|
| Cost | |
| Balance, August 31, 2023 | $2,057,525 |
| Additions | 1,112,399 |
| Translation adjustment | (1,794) |
| Balance, August 31, 2024 | $3,168,130 |
| Additions | 944,187 |
| Translation adjustment | (95,104) |
| Balance, August 31, 2025 | $4,017,213 |
| Accumulated amortization | |
| Balance, August 31, 2023 | $338,571 |
| Amortization | 616,532 |
| Translation adjustment | 1,252 |
| Balance, August 31, 2024 | $956,355 |
| Amortization | 592,942 |
| Translation adjustment | (27,857) |
| Balance, August 31, 2025 | $1,521,440 |
| Net carrying value | |
| August 31, 2025 | $2,495,773 |
| August 31, 2024 | $2,211,775 |
The estimated amortization expense of definite-lived intangible assets is as follows:
| Year ending August 31, | |
|---|---|
| 2026 | 831,925 |
| 2027 | 831,925 |
| 2028 | 831,924 |
| Total | $2,495,774 |
7. Share capital
Authorized share capital
The authorized share capital of the Company consists of an unlimited number of common shares with no par value.
| # | $ | |
|---|---|---|
| Balance, August 31, 2023 | 315,349 | 4,903,031 |
| Issuance of common shares on initial public offering | 43,750 | 3,500,000 |
| Issuance of common share against conversion note | 25,094 | 465,680 |
| Issuance of common shares on equity purchase agreement | 37,149 | 487,491 |
| Share issuance costs | - | (748,063) |
| Warrants issued | - | (48,283) |
| Balance, August 31, 2024 | 421,342 | 8,559,856 |
| Issuance of common shares against S3 | 19,133 | 232,708 |
| Issuance of common shares against prefunded warrants | 64,200 | 780,769 |
| Issuance of common share against S1 | 500,000 | 834,000 |
| Issuance of common shares against warrants conversion | 336,266 | 1,701,398 |
| Share issuance costs | - | (487,263) |
| Balance, August 31, 2025 | 1,340,941 | 11,621,468 |
November 03, 2023 – Initial public offering
In the prior fiscal year (2024), the Company completed its initial public offering on the NYSE American, issuing 43,750 common shares for gross proceeds of approximately $3.5 million. That offering established the Company’s public listing and provided the foundation for the subsequent financings.
November 14, 2024 - Issuance under Form S-3 Offering
On November 14, 2024, the Company issued 382,667 common shares (pre-reverse) at $0.60 per share, for total gross proceeds of approximately $232,708
Following the 1-for-20 reverse stock split implemented in July 2025, this issuance is presented as 19,133 common shares at $12.00 per share.
January – May 2025 - Exercise of Prefunded Warrants
Between January 2025 and May 2025, holders of prefunded warrants exercised 1,284,000 warrants (pre-reverse), resulting in the issuance of 64,200 common shares (post-reverse) for value of $780,769.
May 5, 2025 - Form S-1 Offering
On May 5, 2025, the Company completed a registered public offering under Form S-1, issuing 10,000,000 common shares (pre-reverse) at $0.15 per share (or 500,000 common shares post-reverse) for gross proceeds of approximately $1.5 million.
In connection with this offering, the Company issued 10,000,000 detachable warrants pre reverse split (500,000 detachable warrants after reverse split) each exercisable for one common share at $0.15 per share pre-reverse, or $3.00 per share post-reverse. These warrants were assessed under ASC 480 and ASC 815, Derivatives and Hedging and determined to require liability classification, as certain settlement features are not indexed solely to the Company’s own stock.
The warrant liability was initially recognized at fair value of $659,190 on the issuance date using the Black-Scholes option-pricing model and is remeasured at each reporting date, with changes in fair value recognized in the consolidated statements of operations and comprehensive loss.
Residual proceeds of $834,000 were allocated to common stock within equity, net of issuance costs.
July – August 2025 - Warrant Conversions
During July and August 2025, a total of 336,266 warrants were exercised at an exercise price of $3.00 per share, resulting in the issuance of 336,266 common shares and valuing $1,701,398. Upon exercise, the related portion of the warrant liability was reclassified to equity.
Reverse Stock Split
On July 16, 2025, the Company effected a 20-for-1 reverse stock split of its issued and outstanding common shares (the “Reverse Split”). As a result of the Reverse Split, every twenty (20) common shares issued and outstanding prior to the effective date were automatically combined into one (1) common share. No fractional shares were issued in connection with the Reverse Split; any fractional entitlements were rounded in accordance with the Company’s governing documents.
The Reverse Split did not affect the total shareholders’ equity, the carrying amount of common shares, or the par value of the Company’s common shares.
All share, per-share, warrant, option, and RSU figures presented in these consolidated financial statements and accompanying notes have been retroactively adjusted to reflect the Reverse Split for all periods presented.
Summary of Share Capital
As of August 31, 2025, the Company had 1,340,941 common shares issued and outstanding (August 31, 2024 –421,342) andno preferred shares outstanding.
8. Warrants
| a) | Common Share purchase warrant |
| # | $ | |
|---|---|---|
| Balance, August 31, 2023 | 82,650 | 2,922,853 |
| Share-based compensation expense | - | 33,091 |
| Balance, August 31, 2024 | 82,650 | 2,955,944 |
| Share-based compensation expense | - | 146,870 |
| Balance, August 31, 2025 | 82,650 | 3,102,814 |
| b) | Warrant Liability |
As noted in Note 7 above on November 3, 2023, the Company issued 1,313 warrants at an exercise price of $80.00 with an expiry date of October 31, 2028 and on May 5, 2025 the Company issued 500,000 warrants at an exercise price of $3.00 with an expiry date of May 05, 2030. As per ASC 815 the instruments did not meet the criteria to be classified as equity instruments as such were classified as a financial liability. Below is the continuity of the warrant liability valuation.
The warrants issued on November 3, 2023 were valued using the Black-Scholes method with the share price of $37.20, exercise price of $80, term of 5 years, risk free rate of 3.79% and volatility of 142% at issuance and share price of $4.02, exercise price of $80, term of 3.17 years, risk free rate of 3.59% and volatility of 189% as at August 31, 2025.
The warrants issued in May 2025, were valued using the Black-Scholes method with the share price of $2.54, exercise price of $3.00 term of 5 years, risk free rate of 3.95% and volatility of 170.38% at issuance and share price of $4.02, exercise price of $3.00, term of 4.72 years, risk free rate of 3.97%, and volatility of 188.55% as at August 31, 2025.
| # | $ | |
|---|---|---|
| Balance at August 31, 2023 | - | - |
| Issuance of warrants | 1,313 | 48,283 |
| Issuance of warrants related to the convertible debt | 50,000 | 56,701 |
| Change in fair value of warrant liability | (63,769) | |
| Fair Value of Warrants at August 31, 2024 | 51,313 | 41,520 |
| Change in fair value of expiration of warrants relating to conversion debt | (50,000) | (23,873) |
| Issuance of warrants against S1 | 500,000 | 659,190 |
| Conversion of warrants into shares | (336,266) | (674,914) |
| Change in fair value of warrants liability | 632,410 | |
| Translation adjustment | (1,580) | |
| Fair Value of Warrants at August 31, 2025 | 165,047 | 632,753 |
| August 31, 2025 | August 31, 2024 | |
|---|---|---|
| Weighted average estimated fair value per common share | $2.63 | 0.45 |
| Weighted average exercise price of the warrant | $3.20 | 2.85 |
| Weighted average expected life of the warrant | 4.67 years | 0.85 years |
As at August 31, 2025, the warrants had a weighted-average intrinsic value of $1.02 per warrant or total $167,008 (August 31, 2024 – $nil).
c) Pre-funded warrant
| # | $ | |
|---|---|---|
| Pre-funded warrant issued November 13, 2024 | 64,200 | 780,769 |
| Conversion of warrants into shares | 64,200 | 780,769 |
| Balance, August 31, 2025 | - | - |
The purchase price of each Pre-Funded Warrant was $11.998 (Pre-reverse split $0.5999), which is equal to the price per share at which the Shares are being sold, minus $0.002 (Pre-reverse split $$0.0001), the exercise price of each Pre-Funded Warrant. During the period,64,200 (Pre-reverse split 1,284,000) pre-funded warrants were exercised and converted into the common shares of the Company.
During the fiscal year, the Company recorded $216,856 in expenses attributable to underwriter commissions and legal fees associated with the issuance of the prefunded warrants.
For the years ended August 31, 2024 and 2023
9. Share-based benefits reserve
The Company maintains two equity-based compensation plans, the 2021 Legacy Plan and the 2022 Omnibus Plan, designed to attract, retain, and motivate qualified directors, officers, employees, and consultants whose contributions are important to the Company’s success by offering them an opportunity to participate in the Company’s future performance through share-based awards.
Each stock option granted under the plans entitles the holder to acquire one common share of the Company upon exercise. No amounts are payable by the recipient on receipt of the option. The options carry no dividend or voting rights and may be exercised at any time after vesting and before their expiry date.
The total number of common shares reserved for issuance under the plans is limited to 10% of the Company’s issued and outstanding common shares at any given time.
On June 14, 2021, the Company granted stock options that vest over a two-year period, with 25% vesting on the grant date and the remaining unvested options vesting in equal six-month instalments thereafter. The fair value of these options at the grant date was $1,317,155. No stock-based compensation expense was recognized in relation to these grants for the years ended August 31, 2025 and August 31, 2024.
During the year ended August 31, 2025, pursuant to a Board of Directors resolution dated July 16, 2025, the Company approved the issuance of 46,437 Restricted Share Units (RSUs) for a value of $88,136 under the 2022 Omnibus Plan and 73,570 stock options for a value of $146,870, under the 2021 Legacy Plan. The options were granted with an exercise price equal to the fair market value of the Company’s common shares on the grant date, $1.30 per share. Company is in process of issuing 46,437 shares against the RSUs.
These RSUs and options were granted in recognition of the recipients’ past performance and contributions and were therefore fully vested upon grant, with no remaining service or vesting conditions. The RSUs were valued at the market price of the Company’s common shares on the grant date, and the stock options were valued using the Black-Scholes option-pricing model.
As a result of these grants, the Company recognized a stock-based compensation expense of $235,006 during the year ended August 31, 2025, $Nil during the year ended August 31, 2024.
The following reconciles the options outstanding at the beginning and end of the period that were granted to eligible participants pursuant to the Plan:
| August 31, 2025 | August 31, 2024 | |||
|---|---|---|---|---|
| Number of Options | Weighted Average Exercise Price | Number of Options | Weighted Average Exercise Price | |
| # | $ | # | $ | |
| Balance, beginning of year | 28,284 | 74.40 | 28,284 | 74.40 |
| Granted during the year | 73,570 | 1.30 | - | - |
| Balance as at year end | 101,854 | 28.08 | 28,284 | 74.40 |
| Exercisable as at year end | 101,854 | 28.08 | 28,284 | 74.40 |
As of August 31, 2025, all outstanding stock options were fully vested and exercisable, including those granted during the year with a contractual term of ten (10) years from the grant date (expiring July 16, 2035). The weighted-average remaining contractual life of all options outstanding was approximately 7.35 years (August 31, 2024 –1.8 years). The aggregate intrinsic value of options outstanding at year-end was approximately $200,110, based on the closing market price of $4.02 per share.
10. Right-of-use asset and lease liability
The Company leases all of its office premises in Ontario and British Columbia, Canada under non-cancellable operating lease arrangements accounted for under ASC 842 — Leases.
Ontario Offices
The Company’s head office premises in Ontario comprise approximately 4,894 square feet under a lease that was extended to January 1, 2030. In addition, during fiscal 2024 the Company acquired 8,368 square feet of adjacent space from the same landlord, with the new lease also expiring on January 1, 2030. The combined total area occupied in Ontario is 13,262 square feet.
For purposes of measuring the related lease liability and right-of-use asset under ASC 842, the Company applied an incremental borrowing rate (“IBR”) of 6%, which reflects the Company’s estimated cost of borrowing on a secured basis over a similar term.
British Columbia Office (Lease Surrender)
On May 29, 2023, the Company entered into a lease for 1,454 square feet of office space located atUnit 601 – 2950 Glen Drive, Coquitlam, British Columbia, for afive-year term commencing August 1, 2023 and originally expiring July 31, 2028.
Subsequently, pursuant to a Lease Surrender Agreement with the landlord (RPMG Holdings Ltd.) dated August 21, 2025, the Company agreed to surrender and terminate the lease effective July 31, 2025. Under the terms of the agreement, the Company paid a surrender fee of $24,875 plus GST, and the security deposit was forfeited to the landlord in full settlement of all obligations under the lease.
Lease Surrender Agreement
The surrender resulted in a derecognition (“deletion”) of the associated right-of-use asset and corresponding lease liability in fiscal 2025, with no material gain or loss recognized.
The following schedule shows the movement in the Company’s right-of-use asset:
| Right-of-use asset | |
|---|---|
| Cost | |
| Balance, August 31, 2023 | $1,177,721 |
| Translation adjustment | (42,737) |
| Balance, August 31, 2024 | 1,134,984 |
| Derecognition of asset | (139,723) |
| Translation adjustment | (28,716) |
| Balance, August 31, 2025 | $966,545 |
The right-of-use asset is being depreciated on a straight-line basis over the remaining lease term.
| Accumulated Depreciation | |
|---|---|
| Balance, August 31, 2023 | $217,344 |
| Depreciation | 134,508 |
| Translation adjustment | (45,542) |
| Balance, August 30, 2024 | $306,310 |
| Depreciation | 187,048 |
| Derecognition of asset | (54,337) |
| Translation adjustment | (2,639) |
| Balance, August 31, 2025 | $436,382 |
| Carrying Amount | |
| August 31, 2025 | $530,163 |
| August 31, 2024 | $828,674 |
10. Right-of-use asset and lease liability (continued)
The following schedule shows the movement in the Company’s lease liability during the year:
| August 31, 2025 | August 31, 2024 | |
|---|---|---|
| Balance, beginning of year | $977,107 | $1,107,961 |
| Derecognition of lease | (85,151) | - |
| Interest Expense | 51,431 | 62,604 |
| Lease payments | (206,185) | (196,703) |
| Translation Adjustment | (37,242) | 3,245 |
| Balance, end of year | $699,959 | $977,107 |
| Current | 138,859 | 161,508 |
| Non-Current | 561,100 | 815,599 |
| $699,959 | $977,107 |
The following table provides a maturity analysis of the Company’s lease liability. The amounts disclosed in the maturity analysis are the contractual undiscounted cash flows before deducting interest or finance charges:
| 2026 | 175,823 |
| 2027 | 175,756 |
| 2028 | 186,840 |
| 2029 | 194,757 |
| 2030 | 81,149 |
| Total lease liability | $814,325 |
11. Expenses
The following table provides a breakdown of the selling, general and administrative:
| Year ended | ||
|---|---|---|
| August 31, 2025 | August 31, 2024 | |
| $ | $ | |
| Software Subscription | 747,234 | 898,870 |
| Office and general | 206,180 | 199,756 |
| Professional fees | 291,084 | 414,482 |
| Dues and Subscriptions | 612,476 | 269,106 |
| Rent | 210,206 | 207,560 |
| Consulting fees | 58,890 | 62,598 |
| Travel | 33,288 | 160,643 |
| Donations | 788 | 7,449 |
| Lease expense | 1,805 | 71,148 |
| Insurance | 91,993 | 90,613 |
| Selling, general and administrative | 2,253,944 | 2,382,225 |
12. Related party transactions and balances
Compensation of key management personnel includes the Chief Executive Officer, Chief Operating Officer, Chief Financial Officer:
| August 31, 2025 | August 31, 2024 | |
|---|---|---|
| $ | $ | |
| Salaries, Wages and benefits | 582,734 | 776,278 |
| Share-based compensation | 161,994 | - |
Chief Strategy Officer resigned on March 07, 2025.
13. Deferred government grant
Government grants are recognized when there is reasonable assurance that the grants will be received and the company will comply with the conditions. The grants is deferred and recognized as a liability and is recognized in the statement of operations and compressive loss over the useful life of the intangible asset.
The Company previously qualified for the Government of Canada Scientific Research and Experimental Development (“SR&ED”) program, which provides refundable tax incentives for eligible research and development activities performed in Canada.
The Company’s eligibility under the SR&ED program ceased on November 3, 2023. All SR&ED claims and related receivables were fully recognized in prior fiscal years, andno additional accruals, recoveries, or claims were recorded during the year ended August 31, 2025.
As disclosed in prior years, a portion of the SR&ED proceeds received related to expenditures that had been capitalized as internally generated software. Accordingly, the related government incentive continues to be recognized as deferred income and is amortized to income over the useful life of the associated intangible assets in accordance with the Company’s accounting policy.
The Company does not expect any further SR&ED recoveries in future periods.
14. Risk management arising from financial instruments
| a) | Credit risk |
|---|
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company’s primary exposure to credit risk arises from cash balances held with financial institutions and trade receivables, which consist almost entirely of subscription fees billed to mortgage agents and brokerages.
The Company manages this risk by holding cash only with major Canadian financial institutions and by monitoring the creditworthiness, payment history, and aging profile of all subscription receivables. Trade receivables are short-term in nature and generally collected within 30 to 60 days. The Company considers receivables past due when they exceed 60 days outstanding, and impaired when they exceed 90 days with no reasonable expectation of recovery.
In accordance with ASC 326 – Current Expected Credit Losses (“CECL”), the Company applies a lifetime expected credit loss model to trade receivables. Expected credit losses are estimated using a combination of historical loss rates, aging analysis, forward-looking information, and specific identification of high-risk accounts. Given the Company’s business model and the nature of subscription-based fees, historical credit losses have been limited; however, the Company recognized a material ECL provision and related write-offs during fiscal 2025, reflecting an increase in past-due accounts and a more conservative application of the CECL model.
Accounts Receivable Aging
As of each reporting date, the Company monitors the aging of trade receivables as follows:
| ● | Current (0–60 days) |
| ● | Past Due (61–90 days) |
| ● | Impaired (>90 days) |
2025
| 0-30 days | 30-60 days | 60-90 days | 90 plus days | Total | |
|---|---|---|---|---|---|
| Receivables $ | 31,400 | 7,270 | 35,503 | 64,163 | 138,336 |
| Other receivable | 2,411 | - | - | - | 2,411 |
| Less: Expected credit loss | - | - | - | (48,524) | (48,524) |
| Total | 33,811 | 7,270 | 35,503 | 33,811 | 92,223 |
2024
| 0-30 days | 30-60 days | 60-90 days | 90 plus days | Total | |
|---|---|---|---|---|---|
| Receivables $ | 17,966 | 6,652 | 2,388 | 33,942 | 60,948 |
| Other receivables | 94,276 | - | - | - | 94,276 |
| Less: Expected credit loss | - | - | - | - | - |
| Total | 112,242 | 6,652 | 2,388 | 33,942 | 155,224 |
The maximum exposure to credit risk as of August 31, 2025 is the carrying amount of cash and trade receivables on the consolidated balance sheet. Despite the increase in ECL during the year, management believes overall credit risk remains moderate and manageable, given the Company’s diversified customer base and the short-term nature of its receivables.
The following table provides expected credit loss during the year:
| Year ended | ||
|---|---|---|
| August 31, 2025 | August 31, 2024 | |
| $ | $ | |
| Opening balance | - | - |
| Increased during the year | 48,524 | - |
| Closing balance at year end | 48,524 | - |
| b) | Interest rate risk |
|---|
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market interest rates. The Company does not have any variable interest-bearing debt.
| c) | Liquidity risk |
|---|
Liquidity risk is the risk that the Company may be unable to meet its financial obligations as they become due. The Company manages this risk by monitoring actual and forecasted cash flows on an ongoing basis and assessing available sources of financing, as further described in the Going Concern discussion in Note 1.
As at August 31, 2025, the Company’s contractual payment obligations are as follows:
| Fiscal Year | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| $ | $ | $ | $ | $ | |
| Lease payments | 175,823 | 175,756 | 186,840 | 194,840 | 81,149 |
| Accounts payable | 2,125,160 | - | - | - | - |
| Loan from directors | 629,120 | - | - | - | - |
| Warrant liability | 632,753 | - | - | - | - |
| Total | 3,562,856 | 175,756 | 186,840 | 194,840 | 81,149 |
Management believes that these obligations can be met through existing working-capital resources, expected operating cash flows, and planned financing initiatives.
| d) | Management of capital |
|---|
The Company’s objective of managing capital, comprising of shareholders’ equity, is to ensure its continued ability to operate as a going concern. The Company manages its capital structure and makes changes to it based on economic conditions.
Management and the Board of Directors review the Company’s capital management approach on an ongoing basis and believe this approach, given the relative size of the Company, is reasonable. The Company is not subject to externally imposed capital requirements. The Company’s capital management objectives, policies and processes have remained unchanged during the year ended August 31, 2025.
| e) | Foreign currency risk |
|---|
The Company’s operations and revenues are primarily denominated in Canadian dollars (“CAD”), which is also the functional currency of all of its subsidiaries. Accordingly, day-to-day operating exposure to foreign currencies is limited. However, the Company does incur foreign currency risk from certain USD-denominated transactions, including balances held in USD bank accounts and select vendor payments made in USD. These items can give rise to realized and unrealized foreign exchange gains or losses, which are recorded in the consolidated statements of operations.
In addition, the Company is required to translate its CAD-denominated financial statements into U.S. dollars (“USD”) for SEC reporting. This translation process may result in period-to-period fluctuations in reported assets, liabilities, revenues, and expenses due to changes in the CAD-USD exchange rate. These translation adjustments do not affect the Company’s underlying cash flows or economic performance.
Given the Company’s limited operating exposure to foreign currencies, management does not currently utilize foreign exchange derivatives to manage this risk.
15. Commitments and contingencies
In the ordinary course of operating, the Company may from time to time be subject to various claims or possible claims. Management believes that there are no claims or possible claims that if resolved would either individually or collectively result in a material adverse impact on the Company’s financial position, results of operations, or cash flows. These matters are inherently uncertain, and management’s view of these matters may change in the future.
See note 10 related to lease commitments.
16. Revenue
| Year ended | ||
|---|---|---|
| August 31, 2025 | August 31, 2024 | |
| $ | $ | |
| Gross billing | 17,431,300 | 16,264,172 |
| Commission expense | 15,826,657 | 14,895,885 |
| Revenue | 1,604,644 | 1,368,287 |
| Subscription revenue | 750,042 | 738,697 |
| Insurance | 197,852 | - |
| Sponsorship revenue | 220,923 | 107,741 |
| Underwriting revenue | 125,828 | 153,757 |
| Other revenue | 87,535 | 320,505 |
| Total revenue | 2,986,823 | 2,688,987 |
The Company generates revenue primarily from mortgage brokerage activities, subscription fees, underwriting services, and ancillary technology-enabled services. Revenue is disaggregated by geographic region based on the location of the customer.
For the fiscal years ended August 31, 2025 and August 31, 2024, all revenue was earned in Canada, as the Company operates exclusively within the Canadian mortgage market and has no foreign revenue-generating operations.
17. Loan from directors
During the year ended August 31, 2025, the Company entered into unsecured loan agreements with its directors and shareholders, for total proceeds of $608,940 loans bear interest at 12 percent per annum, are non-compounding, and are repayable after filling of S1 registration statement filling in December 2025. The loans are unsecured and may be repaid at any time without penalty. Total interest during the year was $48,570.
As of August 31, 2025, the outstanding principal and accrued interest are included in loans payable within current liabilities. Management believes the terms of these loans are consistent with those available in arm’s-length commercial transactions.
18. Convertible loan
On May 10, 2024, the Company issued an unsecured convertible debt (‘debt”) of $300,000 carrying a two-year term with interest on the outstanding principal amount from the date of issuance accrued at the rate of 8% per annum. The Company also issued 50,000 (pre-reverse split -1,000,000) warrants with exercise price of $5 in connection with the convertible debt (Note 8).
The Company has an option to prepay the loan prior to the maturity date subject to a prepayment fee of $75,000.
The conversion price of the debt shall equal to 75% of the volume weighted average price (VWAP) on the trading day immediately preceding the conversion date.
The conversion feature of the note was not clearly and closely related to the debt and should be recognized as a derivative liability. The Company determined that the estimate fair value of the derivative liability is $76,543. The prepayment option was not clearly and closely related to the debt and should be recognized a derivative liability. The Company determined the estimated fair value of the prepayment option to be $nil.
The Company incurred debt issuance cost of $94,687 which was applied against the principal of the debt. The debt component of the convertible debt was valued using the effective interest method, based on an estimated effective interest of 46%.
During the year ended August 31, 2024, the Company incurred interest of $4,411 recognized in interest expense in the consolidated statement of operations and comprehensive loss accretion expense of $223,059 recognized in the consolidated statement of operations and comprehensive loss.
The convertible note was converted into shares in July 2024. Company issued 25,094 (Pre-reverse split -501,874) shares against the convertible note and the accrued interest thereon.
19. Income taxes
The reconciliation of the combined federal and state income tax rate of 26.5% (2024 – 26.5%) to the effective tax rate is as follows:
| August 31, 2025 | August 31, 2024 | |
|---|---|---|
| $ | $ | |
| (Loss) before recovery of income taxes | (3,638,465) | (4,102,659) |
| Expected income tax (recovery) expense | (964,193) | (1,087,200) |
| Non-deductible expenses | 265,113 | 112,110 |
| Share issuance cost booked directly to equity | (129,125) | (219,330) |
| Valuation Allowance | 828,205 | 1,194,420 |
| Income tax expense (recovery) | - | - |
Deferred income taxes
The following table summarizes the component of deferred tax
| August 31, 2025 | August 31, 2024 | |
|---|---|---|
| $ | $ | |
| Deferred tax assets | ||
| Intangible assets | 210,730 | 54,750 |
| Property, plant and equipment | 9,760 | - |
| Finance lease liabilities | 185,489 | 258,930 |
| Convertible debentures | - | 6,550 |
| Investments | 3,972 | 5,240 |
| Share issuance costs | 299,391 | 413,950 |
| Operating tax losses carried forward | 3,419,095 | 2,633,950 |
| SR&ED Pool from T661 | 271,748 | 271,750 |
| Charitable donations carryforward | 28,216 | 28,010 |
| Deferred income tax assets | 4,428,402 | 3,673,130 |
| Valuation allowance | (4,287,909) | (3,440,100) |
| Total net deferred tax assets | 140,493 | 233,030 |
| Deferred tax liabilities | ||
| Property, plant and equipment | - | (13,430) |
| Right of use assets | (140,493) | (219,600) |
| Total deferred tax liability | (140,493) | (233,030) |
| Net deferred tax liability | - | - |
The Canadian operating tax loss carry forward expire in 2045. The remaining deductible temporary differences may be carried forward indefinitely.
The Company has adopted the provisions of ASC 740-10, which clarifies the accounting for uncertain tax positions. ASC 740-10 requires that the Company recognize the impact of a tax position in its financial statements if the position is more likely than not to be sustained upon examination based on the technical merits of the position. For the year ended August 31, 2025, the Company had no material unrecognized tax benefits, and based on the information currently available, no significant changes in unrecognized tax benefits are expected in the next 12 months.
20. Other Income
During the year, the Company recorded other income from the sale of certain insurance book assets, representing proceeds received for transferring renewal rights and related customer relationships. The Company has no ongoing obligations following the transfer.
21. Subsequent events
Subsequent to August 31, 2025, the Company entered into several material financing and digital-asset transactions. Management has evaluated these events in accordance with ASC 855,Subsequent Events, and determined that they represent non-recognized subsequent events requiring disclosure but no adjustment to the consolidated financial statements as of and for the year ended August 31, 2025.
| a) | Injective Digital Asset Treasury Initiative |
On September 2, 2025, the Company entered into a Securities Purchase Agreement with certain accredited investors to issue 24,642,700 subscription receipts at an offering price of $3.80 per subscription receipt, with respect to certain purchasers, and $4.16 per subscription receipt, with respect to certain purchasers.
The private placement closed on September 4, 2025, raising approximately $100 million in aggregate proceeds consisting of cash and Injective (INJ) tokens, all of which are held in escrow pending satisfaction of specified escrow release conditions under the Subscription Receipt Agreement.
On October 31, 2025, shareholders approved the issuance of the underlying common shares. The Company is preparing a registration statement on Form S-1 to register the resale of approximately 25.7 million shares, including those issuable upon exercise of associated warrants. Escrowed funds will be released upon SEC effectiveness of the registration statement and NYSE American approval of listing of the underlying shares.
| b) | Voltedge Loan Facility |
On September 15, 2025, the Company executed a Master Loan and Security Agreement with Voltedge Finance Inc., providing for a revolving credit facility of up to $15.0 million. As of November 2025, $11.8 million had been drawn under the facility and invested in INJ tokens as part of the Company’s digital-asset treasury strategy. The facility is secured by a corporate guarantee from Coopers Financial Group and pledges over certain digital-asset holdings.
| c) | White Lion Equity Line of Credit (ELOC) |
On September 4, 2025, the Company entered into a Common Stock Purchase Agreement with White Lion Capital LLC, establishing an equity line of credit of up to $250 million. The agreement allows the Company, at its discretion, to issue and sell common shares over a 24-month period, subject to volume and pricing limitations. As of the date of issuance of these consolidated financial statements, no shares have been issued, and the arrangement has not yet been registered with the SEC.
| c) | Warrants Expiry |
Subsequent to year-end,82,650 warrants originally issued in connection with the Company’s prior financing arrangements reached their contractual maturity date on November 3, 2025, which was two years following the defined liquidity event. In accordance with the terms of the warrant agreements, these warrants expired unexercised and are no longer outstanding as of that date. No cash settlement or further obligation arose to the Company upon expiry.
Management concluded that these transactions occurred after year-end and therefore did not require adjustment to the accompanying consolidated financial statements. The Company will continue to monitor subsequent developments related to the escrow releases, SEC registration processes, and loan facility utilization for disclosure in future filings.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.